phMRI: methodological considerations for mitigating potential confounding factors
Open Access
- 7 May 2015
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neuroscience
- Vol. 9, 167
Abstract
Pharmacological Magnetic Resonance Imaging (phMRI) is a variant of conventional MRI that adds pharmacological manipulations in order to study the effects of drugs, or uses pharmacological probes to investigate basic or applied (e.g. clinical) neuroscience questions. Issues that may confound the interpretation of results from various types of phMRI studies are briefly discussed, and a set of methodological strategies that can mitigate these problems are described. These include strategies that can be employed at every stage of investigation, from study design to interpretation of resulting data, and additional techniques suited for use with clinical populations are also featured. Pharmacological MRI is a challenging area of research that has both significant advantages and formidable difficulties, however with due consideration and use of these strategies many of the key obstacles can be overcome.Keywords
This publication has 50 references indexed in Scilit:
- Functional and Pharmacological MRI in Understanding Brain Function at a Systems Level2011
- Imaging brain regional and cortical laminar effects of selective D3 agonists and antagonistsPsychopharmacology, 2010
- Using MRI to measure drug action: caveats and new directionsJournal of Psychopharmacology, 2010
- Pharmacologic Neuroimaging of the Ontogeny of Dopamine Receptor FunctionDevelopmental Neuroscience, 2010
- Caffeine attenuates practice effects in word stem completion as measured by fMRI BOLD signalHuman Brain Mapping, 2006
- The role of fMRI in drug discoveryJournal of Magnetic Resonance Imaging, 2006
- Dopamine antagonist modulation of amphetamine response as detected using pharmacological MRINeuropharmacology, 2005
- Catechol O -methyltransferase val
158
-met genotype and individual variation in the brain response to amphetamineProceedings of the National Academy of Sciences, 2003
- COMT
val
158
met
Genotype Affects µ-Opioid Neurotransmitter Responses to a Pain StressorScience, 2003
- A hypercapnia-based normalization method for improved spatial localization of human brain activation with fMRINMR in Biomedicine, 1997